Statement on Final 340b Drug Pricing Program Ceiling Price and Civil Monetary Penalties Rule

Tom Nickels
Executive Vice President
American Hospital Association

November 29, 2018


The AHA is pleased that in response to our lawsuit, today’s final rule ensures that the implementation of the long-delayed 340B Drug Pricing Program ceiling price and civil monetary penalties policies will be effective January 1, 2019. Earlier this year, the AHA along with other national organizations representing 340B hospitals, filed a lawsuit to force implementation of this rule in order to shine needed light on drug pricing and to hold price-gouging drug companies accountable. We continue to strongly urge HHS to make available online drug pricing information for 340B hospitals as this rule requires as soon as possible after January 1, and no later than April 1, so that instances of drug company overcharging can be uncovered and penalties enforced.


About the American Hospital Association
The AHA is a not-for-profit association of health care provider organizations and individuals that are committed to the improvement of health in their communities. The AHA is the national advocate for its members, which include nearly 5,000 hospitals, health care systems, networks and other providers of care. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. For more information, visit https://www.aha.org

 

###

Contact:        

Marie Johnson, (202) 626-2351

Colin Milligan, (202) 638-5491

Related Resources

Press Releases
Action Alert
Member
The Senate Committee on Health, Education, Labor and Pensions has released the Lower Health Care Costs Act of 2019 – bipartisan discussion draft legislation to…
Press Releases
Public
Legal Documents
Public
Legal Documents
Public
Fact Sheets
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…